[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
August 18, 1956


Author Affiliations


From the Harrison Department of Surgical Research, Schools of Medicine, University of Pennsylvania, and the Department of Urology, Hospital of the University of Pennsylvania.

JAMA. 1956;161(16):1564-1565. doi:10.1001/jama.1956.62970160002010a

Despite the many new antibiotics that have been introduced during recent years, certain sulfonamide preparations still maintain a position of great usefulness in the management of urinary tract infections. Their high degree of effectiveness against the common invaders of the urinary system and their low cost, low toxicity, and ease of administration are a few of the reasons for their wide clinical acceptance.

A recent modification of the basic sulfonamide radical toward greater solubility has led to the development and introduction of Elkosin [N1-(2, 6-dimethyl-4-pyrimidyl) sulfanilamide]. Zeigler, Bagdon, and Shabica1 in an in vitro solubility study of six therapeutically active forms of the commonly used sulfonamides found Elkosin "... clearly the most soluble drug in the entire sulfapyrimidine class in the pH range 4-7." Since infection tends toward a lowering of the urinary pH, this high solubility of Elkosin in the lower physiological ranges is of particular importance

First Page Preview View Large
First page PDF preview
First page PDF preview